Peer Review History

Original SubmissionJanuary 12, 2024
Decision Letter - Shazia Khalid, Editor

PONE-D-24-01617The Evaluation General Health Questionnaire (GHQ-12) Reliability Generalization: A Meta-AnalysisPLOS ONE

Dear Dr. Ajele,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but needs few changes. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 30 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Shazia Khalid, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following in your Competing Interests section:  

"NO authors have competing interests."

Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state ""The authors have declared that no competing interests exist."", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now 

 This information should be included in your cover letter; we will change the online submission form on your behalf.

3. Please provide a complete Data Availability Statement in the submission form, ensuring you include all necessary access information or a reason for why you are unable to make your data freely accessible. If your research concerns only data provided within your submission, please write "All data are in the manuscript and/or supporting information files" as your Data Availability Statement.

4. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Dear Author,

The manuscipt is accepted with monir changes, which are given below:

1. The Introduction and Discussion section needs to more detailed with recent references.

2. Inclusion and exclusion criteria should be clearly mentioned.

3. The article needs to be reviewed for grammatical mistakes.

Thank you.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Overall this research article seems quite coherent. It covered all of its obejctve clearly. I recommend to make discussion section more argumentatve rather than simply reaching to conlcusions abruptly, authors should build a logcal argument. I think more discussion and analysis is need in discussion section. Make sure toclealry state all point that this study discovered. Moroever there are few typo errors on page 5, 7, 17 & 18. Please recheck. These errors include absence of dot at the end of sentence or other typo errors. Moroever, in sytematic review research we expect it to be more detailed and indepth.This point is lacking in this research specifically in introduction and discsussion section. Please clearly state why you inlcuded certan studies and exlcuded other. Please elaboartae exclusion and inlcusion criteria. Moreover, also mention rational behind it.

Reviewer #2: Overall the research paper impressively and thoroughly explored an essential subject but I would like to share few recommendations.

1. your title should include a word "of" before General health questionnaire as it is creating a little confusion in understanding.

2. Method section of Abstract (4th line) should end with the word "results" (unbiased results) for better understanding.

3. Paper should include a more robust literature review and rationale with reference to the usage of GHQ in diverse populations, cultures and languages.

4. The paper's quality is uplifted by the careful attention given to its methodology regarding the screening procedure but it lacks in understanding of Inclusion criteria. Must add a more clear and specified inclusion criteria regarding diversity of studies. so that it may relate well with the results. Add well explained Procedure in method section.

5. The results section related to Test-Retest reliability is not providing enough information for a good understanding. I would suggest to revise this part.

6. The results regarding "heterogeneity" needs more explanation.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Rukhshanda Majeed

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Dear Dr. Khalid and Reviewers,

we would like to express my gratitude for the time and effort invested in the thorough evaluation of my manuscript titled "The Evaluation General Health Questionnaire (GHQ-12) Reliability Generalization: A Meta-Analysis" with Manuscript ID PONE-D-24-01617. We appreciate the insightful comments and constructive feedback provided by both the academic editor and the reviewers.

We carefully considered each comment and implemented the necessary revisions to address the concerns raised during the review process. Below is a point-by-point response to the comments and a summary of the changes made:

Reviewer 1

Discussion Section: we expanded the Discussion section, providing more detailed arguments and logical connections to the study's objectives and findings. This includes a comprehensive analysis of the discovered points.

Typos and Aesthetic Presentation: We thoroughly reviewed the manuscript for typographical errors and addressed the identified typos on pages 5, 7, 17, and 18. The overall aesthetic presentation of the systematic review has been improved for clarity.

Inclusion and Exclusion Criteria: We clearly stated the inclusion and exclusion criteria for the systematic review in both the methods and introduction sections. Additionally, I have provided a detailed rationale for the selection of studies, explaining why certain studies were included, and others were excluded.

Reviewer 2

Title Revision: We revised the title to include the word "of" before "General Health Questionnaire" for better clarity.

Abstract Method Section and Literature Review: The Method section of the abstract has been revised to end with the word "results" for improved understanding. The literature review and rationale have been strengthened by incorporating more robust references related to the usage of GHQ in diverse populations, cultures, and languages.

Inclusion Criteria Explanation: We provided a more clear and specified inclusion criteria section regarding the diversity of studies, ensuring it relates well to the results. A well-explained procedure has been added to the Method section.

Test-Retest Reliability and Heterogeneity: The results related to test-retest reliability have been revised to provide more information for better understanding. The section on heterogeneity has been explained more thoroughly to enhance clarity.

We also addressed the additional journal requirements, including style guidelines, competing interests, data availability statement, ethics statement, supporting information captions, and reference list review. All these changes are reflected in the attached documents: 'Response to Reviewers,' 'Revised Manuscript with Track Changes,' and 'Manuscript.'

We appreciate your guidance and constructive feedback, which have undoubtedly improved the quality of the manuscript. We are confident that the revised version meets the standards for publication in PLOS ONE.

Thank you for your time and consideration. I look forward to any further feedback and the opportunity to proceed with the publication process.

Best regards,

Dr. KW Ajele

Decision Letter - Shazia Khalid, Editor

The Evaluation of General Health Questionnaire (GHQ-12) Reliability Generalization: A Meta-Analysis

PONE-D-24-01617R1

Dear Autrhor,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Shazia Khalid, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Shazia Khalid, Editor

PONE-D-24-01617R1

PLOS ONE

Dear Dr. Wojujutari,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Shazia Khalid

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .